Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000221285 | SCV000277118 | likely benign | Hereditary cancer-predisposing syndrome | 2015-07-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000556680 | SCV000622761 | likely benign | Ataxia-telangiectasia syndrome | 2024-01-14 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000221285 | SCV000687779 | likely benign | Hereditary cancer-predisposing syndrome | 2017-08-14 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001798720 | SCV002042907 | likely benign | Breast and/or ovarian cancer | 2020-01-31 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004591000 | SCV005084821 | benign | Familial cancer of breast | 2024-06-14 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004701293 | SCV005204964 | likely benign | not specified | 2024-06-09 | criteria provided, single submitter | clinical testing |